FG Syndrome

Search Trials
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Aug 7, 2019
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION
Status:
Terminated
Last Changed:
Aug 7, 2013
First Changed:
Jun 28, 2011
Disease(s):
Cholestasis, Progressive Familial Intrahepatic 3
Intervention(s):
Yttrium microsphere injection
Efficacy and Safety of FG-4592 for Treatment of Anemia in Subjects With Lower Risk MDS
Status:
Recruiting
Last Changed:
Aug 6, 2018
First Changed:
Oct 5, 2017
Disease(s):
Primary MDS Classified as Very Low, Low or Intermediate Risk With <5% Blasts
Intervention(s):
FG-4592Placebo
Efficacy and Safety of FG-4592 for Treatment of Anemia in Patients With Lower Risk MDS With Low Red Blood Cell Transfusion Burden
Status:
Recruiting
Last Changed:
Aug 29, 2018
First Changed:
Aug 28, 2017
Disease(s):
Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)
Intervention(s):
FG-4592Placebo

Connect. Empower. Inspire.